Personalized Medicine Biomarkers Market
完整報告名稱與涵蓋範圍
Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Distribution by Type (Genetic Biomarkers, Protein Biomarkers, Metabolite Biomarkers), By Application (Oncology, Neurology, Diabetes, Autoimmune Diseases, Cardiology, Others), By End User (Hospitals, Diagnostic Laboratories, Research Institutions) and Segment Forecasts, 2024-2031
報告摘要
In 2023, the Personalized Medicine Biomarkers Market worldwide was assessed at USD 22.9 Bn. Analysts project it will develop to USD 59.1 Bn by 2031, at a CAGR of 12.8% spanning 2024 to 2031.
Personalized Medicine Biomarkers covers The Personalized Medicine Biomarkers Market represents a continuously developing area of healthcare focused on using biomarkers, which are biological markers such as proteins or genetic mutations for individu. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is fueled by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Personalized Medicine Biomarkers Market Snapshot
Chapter 4. Global Personalized Medicine Biomarkers Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Personalized Medicine Biomarkers Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Personalized Medicine Biomarkers Industry Trends
Chapter 5. Personalized Medicine Biomarkers Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. Market Share by Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type:
5.2.1. Genetic Biomarkers
5.2.2. Protein Biomarkers
5.2.3. Metabolite Biomarkers
Chapter 6. Personalized Medicine Biomarkers Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Diabetes
6.2.4. Autoimmune Diseases
6.2.5. Cardiology
6.2.6. Others
Chapter 7. Personalized Medicine Biomarkers Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:
7.2.1. Hospitals
7.2.2. Diagnostic Laboratories
7.2.3. Research Institutions
Chapter 8. Personalized Medicine Biomarkers Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. Global Personalized Medicine Biomarkers Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.2.3. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.4. North America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.3. Europe
8.3.1. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.3.3. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.4. Europe Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.4.3. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts By Application, 2019-2031
8.4.4. Asia Pacific Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.5. Latin America
8.5.1. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Country, 2019-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.5.3. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.4. Latin America Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Type, 2019-2031
8.6.3. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.6.4. Middle East & Africa Personalized Medicine Biomarkers Market Revenue (US$ Million) Estimates and Forecasts by End User, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Agilent Technologies, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Bio-Rad Laboratories, Inc.
9.2.3. Foundation Medicine, Inc.
9.2.4. Genomic Health, Inc
9.2.5. Guardant Health, Inc.
9.2.6. Illumina, Inc.
9.2.7. Luminex Corporation
9.2.8. Merck KGaA
9.2.9. Myriad Genetics, Inc
9.2.10. QIAGEN N.V
9.2.11. Roche Diagnostics
9.2.12. Siemens Healthineers
9.2.13. Thermo Fisher Scientific Inc.
9.2.14. Coriell Life Sciences.
9.2.15. Laboratory Corporation of America Holding
9.2.16. NeoGenomics Laboratories
9.2.17. Quest Diagnostics Incorporated
9.2.18. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們